Relmada Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
RLMD Nasdaq 2830 www.relmada.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Relmada Therapeutics, Inc.

Insider Spends US$395k Buying More Shares In Relmada Therapeutics - Sep 13th, 2024 10:13 am
Insider Buying: CFO Maged Shenouda Acquires Shares of Relmada Therapeutics Inc (RLMD) - Sep 12th, 2024 5:07 am
Relmada Therapeutics Inc (RLMD) CEO Sergio Traversa Acquires 140,000 Shares - Sep 12th, 2024 5:06 am
Will Relmada Therapeutics (NASDAQ:RLMD) Spend Its Cash Wisely? - Aug 21st, 2024 10:22 am
Relmada Therapeutics (RLMD) Loses -43.35% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Aug 12th, 2024 1:35 pm
Q2 2024 Relmada Therapeutics Inc Earnings Call - Aug 8th, 2024 5:51 pm
Relmada Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - Aug 7th, 2024 8:05 pm
Institutional investors have a lot riding on Relmada Therapeutics, Inc. (NASDAQ:RLMD) with 48% ownership - Jul 11th, 2024 7:42 pm
Relmada Therapeutics Announced Publication of Results from the Phase 3 Reliance I Study of REL-1017 in The Journal of Clinical Psychiatry - Jun 18th, 2024 12:30 pm
Relmada Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference - Jun 10th, 2024 11:30 am
Relmada Therapeutics to Participate in the 2024 Jefferies Global Healthcare Conference - Jun 3rd, 2024 11:30 am
7 Penny Biotech Stocks to Triple Your Investment - May 28th, 2024 10:10 am
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q1 2024 Earnings Call Transcript - May 11th, 2024 12:41 pm
Q1 2024 Relmada Therapeutics Inc Earnings Call - May 9th, 2024 10:20 am
Relmada Therapeutics Inc (RLMD) (Q1 2024) Earnings Call Transcript Highlights: Strategic ... - May 9th, 2024 7:40 am
Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results - May 8th, 2024 8:05 pm
Relmada Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024 - May 6th, 2024 11:30 am
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript - Mar 20th, 2024 2:27 pm
Q4 2023 Relmada Therapeutics Inc Earnings Call - Mar 20th, 2024 10:27 am
Relmada Therapeutics Inc Reports Full-Year and Q4 2023 Financial Results - Mar 19th, 2024 9:31 pm